Cargando…

Protection and Alleviated Inflammation Induced by Virus-like Particle Vaccines Containing Plasmodium berghei MSP-8, MSP-9 and RAP1

Virus-like particles (VLP) are a highly efficient vaccine platform used to present multiple antigenic proteins. Merozoite surface protein 8 (MSP-8), 9 (MSP-9) and rhoptry-associated protein 1 (RAP1) of Plasmodium berghei are the important proteins in erythrocyte invasion and the replication of paras...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Su-Hwa, Chu, Ki-Back, Kang, Hae-Ji, Quan, Fu-Shi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875819/
https://www.ncbi.nlm.nih.gov/pubmed/35214662
http://dx.doi.org/10.3390/vaccines10020203
_version_ 1784658023451459584
author Lee, Su-Hwa
Chu, Ki-Back
Kang, Hae-Ji
Quan, Fu-Shi
author_facet Lee, Su-Hwa
Chu, Ki-Back
Kang, Hae-Ji
Quan, Fu-Shi
author_sort Lee, Su-Hwa
collection PubMed
description Virus-like particles (VLP) are a highly efficient vaccine platform used to present multiple antigenic proteins. Merozoite surface protein 8 (MSP-8), 9 (MSP-9) and rhoptry-associated protein 1 (RAP1) of Plasmodium berghei are the important proteins in erythrocyte invasion and the replication of parasites. In this study, we generated three VLPs expressing MSP-8, MSP-9 or RAP1 together with influenza virus matrix protein M1 as a core protein, and the protection and alleviated inflammation induced by VLP immunization were investigated. Mice were immunized with a mixture of three VLPs, MSP-8, MSP-9 and RAP1, and challenge-infected with P. berghei. As a result, VLPs immunization elicited higher levels of P. berghei or VLPs-specific IgG antibody responses in the sera upon boost compared to that upon prime and naive. Upon challenge infection with P. berghei, higher levels of CD4+ T cell and memory B cell responses in the spleen were also found in VLPs-immunized mice compared to non-immunized control. Importantly, VLP immunization significantly alleviated inflammatory cytokine responses (TNF-α, IFN-γ) both in the sera and spleen. VLP vaccine immunization also assisted in diminishing the parasitic burden in the peripheral blood and prolonged the survival of immunized mice. These results indicated that a VLPs vaccine containing MSP-8, MSP-9 and RAP1 could be a vaccine candidate for P. berghei infection.
format Online
Article
Text
id pubmed-8875819
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88758192022-02-26 Protection and Alleviated Inflammation Induced by Virus-like Particle Vaccines Containing Plasmodium berghei MSP-8, MSP-9 and RAP1 Lee, Su-Hwa Chu, Ki-Back Kang, Hae-Ji Quan, Fu-Shi Vaccines (Basel) Article Virus-like particles (VLP) are a highly efficient vaccine platform used to present multiple antigenic proteins. Merozoite surface protein 8 (MSP-8), 9 (MSP-9) and rhoptry-associated protein 1 (RAP1) of Plasmodium berghei are the important proteins in erythrocyte invasion and the replication of parasites. In this study, we generated three VLPs expressing MSP-8, MSP-9 or RAP1 together with influenza virus matrix protein M1 as a core protein, and the protection and alleviated inflammation induced by VLP immunization were investigated. Mice were immunized with a mixture of three VLPs, MSP-8, MSP-9 and RAP1, and challenge-infected with P. berghei. As a result, VLPs immunization elicited higher levels of P. berghei or VLPs-specific IgG antibody responses in the sera upon boost compared to that upon prime and naive. Upon challenge infection with P. berghei, higher levels of CD4+ T cell and memory B cell responses in the spleen were also found in VLPs-immunized mice compared to non-immunized control. Importantly, VLP immunization significantly alleviated inflammatory cytokine responses (TNF-α, IFN-γ) both in the sera and spleen. VLP vaccine immunization also assisted in diminishing the parasitic burden in the peripheral blood and prolonged the survival of immunized mice. These results indicated that a VLPs vaccine containing MSP-8, MSP-9 and RAP1 could be a vaccine candidate for P. berghei infection. MDPI 2022-01-27 /pmc/articles/PMC8875819/ /pubmed/35214662 http://dx.doi.org/10.3390/vaccines10020203 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lee, Su-Hwa
Chu, Ki-Back
Kang, Hae-Ji
Quan, Fu-Shi
Protection and Alleviated Inflammation Induced by Virus-like Particle Vaccines Containing Plasmodium berghei MSP-8, MSP-9 and RAP1
title Protection and Alleviated Inflammation Induced by Virus-like Particle Vaccines Containing Plasmodium berghei MSP-8, MSP-9 and RAP1
title_full Protection and Alleviated Inflammation Induced by Virus-like Particle Vaccines Containing Plasmodium berghei MSP-8, MSP-9 and RAP1
title_fullStr Protection and Alleviated Inflammation Induced by Virus-like Particle Vaccines Containing Plasmodium berghei MSP-8, MSP-9 and RAP1
title_full_unstemmed Protection and Alleviated Inflammation Induced by Virus-like Particle Vaccines Containing Plasmodium berghei MSP-8, MSP-9 and RAP1
title_short Protection and Alleviated Inflammation Induced by Virus-like Particle Vaccines Containing Plasmodium berghei MSP-8, MSP-9 and RAP1
title_sort protection and alleviated inflammation induced by virus-like particle vaccines containing plasmodium berghei msp-8, msp-9 and rap1
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875819/
https://www.ncbi.nlm.nih.gov/pubmed/35214662
http://dx.doi.org/10.3390/vaccines10020203
work_keys_str_mv AT leesuhwa protectionandalleviatedinflammationinducedbyviruslikeparticlevaccinescontainingplasmodiumbergheimsp8msp9andrap1
AT chukiback protectionandalleviatedinflammationinducedbyviruslikeparticlevaccinescontainingplasmodiumbergheimsp8msp9andrap1
AT kanghaeji protectionandalleviatedinflammationinducedbyviruslikeparticlevaccinescontainingplasmodiumbergheimsp8msp9andrap1
AT quanfushi protectionandalleviatedinflammationinducedbyviruslikeparticlevaccinescontainingplasmodiumbergheimsp8msp9andrap1